What the GLP

A cultural shift toward downsizing fueled by a GLP-1 drug boom and slimming celebrities is destabilizing for people trying to achieve acceptance, mental health experts and body positivity advocates tell Axios.
Why it matters: Still, the body positivity movement, advocates say, is an ongoing fight that won't shrink with the trends.
"Our brains must see evidence of body diversity," saysZoë Bisbing, a psychotherapist and the founder of Body-Positive Therapy NYC. If we don't, "our brains clock our bodies as wrong."
Flashback: Following the heroin-chic aesthetic of the '90s and early aughts, the 2010s brought curvy anthem "All About That Bass" and an attempt from some brands to elevate more realistic body standards.
But now, the pendulum seems to be swinging back toward media highlighting ultra-thinness, aided by access to GLP-1s and spotlighting celebrities who have slimmed down quickly.
What they're saying: "It absolutely feels like backtracking," says Katelyn Baker, a doctor of clinical psychology who shares body positivity content on TikTok as @thatfatdoctor.
"It hurts my heart because of all the work that I personally poured in, as well as all my friends and my colleagues and people who came before me," she said. "They're kind of disappearing."
Cassandra Cavallaro, a content creator who promotes movement for wellness rather than weight loss, says the rise of the now-banned "SkinnyTok" hashtag sent a "really concerning" message that "bodies are now becoming a trend again."
She emphasizes, "Real people's bodies aren't a trend."
Even stars are noticing the return of harmful appearance norms among fellow celebrities: Actress Jameela Jamil said in a recent video, "this is not just a health kick that Hollywood has undergone."
She continued, "We fought the system [with body positivity], and now we need to come back and do that again."
Between the lines: For those without the resources, Yeshiva University social work professor Dr. Nafees Alam says, the proliferation of drugs widens a two-tiered societal split between those who can afford medical intervention and those who have to "settle" for body positivity.
Systemic barriers to weight management are nothing new, he notes: "Health has been a privilege for those who are socioeconomically affluent for a very long time."
Worth noting: GLP-1s can bring relief to those who need them and offer widespread health benefits beyond Type 2 diabetes management, such as reduced risk of neurological issues and sleep apnea.
Samhita Mukhopadhyay, a body positivity proponent and contributing writer at The Cut, told NPR that "our obsession with celebrities taking them has created an environment where we are not actually evaluating these drugs for their real value."
The drugs also carry side effects, including nausea, headaches and fatigue. In rare cases, there is an increased risk of GI disorders such as pancreatitis.
Health experts have argued the language we use to describe these drugs should frame them as a tool to treat a chronic disease rather than a vanity product. It's part of a broader growing awareness that the language clinicians use language to describe their patients can impact health.
Cavallaro says she doesn't see GLP-1 drugs as "inherently bad."
But the visibility of the weight-loss craze, she says, "brings up all this comparison and second-guessing of our bodies, especially for people who were starting to maybe feel OK ... Now they're questioning, should I be doing more? Should I be smaller?"
The bottom line: The body positivity movement, rooted in the 1960's push for fat rights, is more than just a hashtag or a trend — it's a battle for social justice that blazes on, Bisbing explains.
• "It's not you must love your body as you are," says Bisbing. "It's saying, 'Whoever you are, you have a right to love your body.'"

Facts Only

Zoë Bisbing, a psychotherapist and founder of Body-Positive Therapy NYC, states that lack of body diversity in media can make people perceive their bodies as "wrong."
Katelyn Baker, a clinical psychologist and TikTok creator (@thatfatdoctor), describes the current trend toward thinness as "backtracking" on body positivity progress.
Cassandra Cavallaro, a wellness content creator, highlights the rise and subsequent banning of the "SkinnyTok" hashtag as a concerning trend.
Actress Jameela Jamil criticizes Hollywood's return to harmful appearance norms, calling for renewed advocacy.
Dr. Nafees Alam, a social work professor at Yeshiva University, notes that GLP-1 drugs widen societal divides between those who can afford medical interventions and those who cannot.
GLP-1 drugs are used to manage Type 2 diabetes and have additional health benefits, such as reducing neurological risks and sleep apnea.
Side effects of GLP-1 drugs include nausea, headaches, fatigue, and rare cases of gastrointestinal disorders like pancreatitis.
Samhita Mukhopadhyay, a body positivity advocate, argues that celebrity use of GLP-1s distracts from their medical value.
The body positivity movement originated in the 1960s as part of the fat rights movement.
Advocates emphasize that body positivity is about affirming the right to love one's body, not mandating self-love.

Executive Summary

A cultural shift toward downsizing, driven by the popularity of GLP-1 weight-loss drugs and celebrities embracing slimmer physiques, is creating challenges for body positivity advocates and mental health experts. The movement, which gained momentum in the 2010s with efforts to promote body diversity, now faces backlash as media and social trends increasingly highlight ultra-thinness. Advocates argue this reversal undermines progress in accepting diverse body types, with some noting the emotional toll of seeing hard-won representation fade. Meanwhile, GLP-1 drugs, while beneficial for managing conditions like Type 2 diabetes, are being co-opted as vanity tools, amplifying societal pressures around weight. Experts emphasize that body positivity is not about mandating self-love but affirming the right to exist without judgment. The debate also underscores systemic inequities, as access to weight-loss drugs and healthcare remains uneven, reinforcing privilege gaps. The conversation reflects broader tensions between medical advancements, cultural trends, and the ongoing struggle for body autonomy.

Full Take

The strongest version of this narrative highlights a legitimate tension: medical advancements like GLP-1 drugs, while beneficial for health, are being co-opted by cultural forces that prioritize thinness over well-being. The piece credibly frames this as a setback for body positivity, which has fought to normalize diverse body types. However, the analysis risks oversimplifying the relationship between medical treatment and societal beauty standards. The focus on celebrity influence and social media trends (e.g., "SkinnyTok") could be seen as emotional exploitation (ARC-0012), leveraging outrage over body image to drive engagement. The piece also subtly frames the issue as a binary—body positivity vs. medical progress—without fully exploring how these forces might coexist or conflict in more nuanced ways.
Root cause: The narrative assumes that cultural trends are the primary driver of body image struggles, rather than deeper systemic issues like healthcare access or economic inequality. It echoes historical cycles where medical tools (e.g., diet pills, cosmetic surgery) are repurposed for aesthetic ideals, reinforcing privilege gaps. The implication is that body positivity must constantly defend itself against commercial and medical forces that commodify appearance.
Who benefits? Pharmaceutical companies and media outlets profit from the hype around GLP-1s, while celebrities gain social capital by conforming to thinness norms. Who bears costs? Those without access to these drugs or who feel pressured to meet unrealistic standards. Second-order consequences include eroding trust in medical treatments and deepening body image anxieties.
Bridge questions: How might body positivity advocates reframe the conversation to include medical advancements without surrendering to aesthetic pressures? What role should clinicians play in distinguishing between health and vanity in weight-loss discussions? Would the narrative shift if GLP-1s were marketed solely for chronic disease management?
Counterstrike scan: A coordinated influence campaign would amplify celebrity endorsements of GLP-1s while downplaying side effects, framing body positivity as "anti-science." The actual content does not match this pattern; it critically examines both sides and acknowledges the drugs' medical benefits. The piece leans toward advocacy but avoids outright manipulation.
Patterns detected: ARC-0012 Emotional Exploitation (mild)